We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$677K
Cap. Flow
-$15.8M
Cap. Flow %
-13.74%
Top 10 Hldgs %
55.42%
Holding
157
New
40
Increased
38
Reduced
31
Closed
26

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$1.3M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$605K
3
NTES icon
NetEase
NTES
+$589K
4
CP icon
Canadian Pacific Kansas City
CP
+$531K
5
OTIC
Otonomy, Inc.
OTIC
+$432K

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$1.9M
2
VGR
Vector Group Ltd.
VGR
+$774K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$690K
4
SILC icon
Silicom
SILC
+$367K
5
MA icon
Mastercard
MA
+$361K

Sector Composition

Rank Sector Weight
1 Technology 6.64%
2 Consumer Discretionary 4.92%
3 Communication Services 4.55%
4 Healthcare 3.41%
5 Real Estate 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PALI icon
126
CALL
Palisade Bio
PALI
$353M
– –
-1
Closed -$43K
PALI icon
127
PUT
Palisade Bio
PALI
$353M
– –
0
– -$30K
PERI icon
128
Perion Network
PERI
$371M
– –
-34,000
Closed -$201K
RCKT icon
129
CALL
Rocket Pharmaceuticals
RCKT
$355M
– –
-15,675
Closed -$12K
SAGE
130
CALL
DELISTED
Sage Therapeutics
SAGE
– –
-38,300
Closed -$975K
XLB icon
131
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
– –
-8,366
Closed -$225K
TVRD
132
Tvardi Therapeutics
TVRD
$23.8M
– –
-89
Closed -$50K
TVRD
133
PUT
Tvardi Therapeutics
TVRD
$23.8M
– –
-800
Closed -$92K
VGR
134
DELISTED
Vector Group Ltd.
VGR
– –
-59,577
Closed -$774K
ARAV
135
DELISTED
Aravive, Inc. Common Stock
ARAV
$0 ﹤0.01%
+50
New +$5.04K
ZYNE
136
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-46,600
Closed -$229K
ZYNE
137
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-43
Closed -$1K
ZYNE
138
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-61,600
Closed -$394K
SIOX
139
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-50
Closed -$1K
OTIC
140
CALL
DELISTED
Otonomy, Inc.
OTIC
– –
-39,200
Closed -$274K
CTB
141
DELISTED
Cooper Tire & Rubber Co.
CTB
– –
-6,500
Closed -$235K
MNK
142
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-12,800
Closed -$20K
TTPH
143
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-1,466
Closed -$209K
TTPH
144
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-3,630
Closed -$44K
2 3 4 5
6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Worth Venture Partners held 157 positions worth $115M, down 0.58% from $116M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Worth Venture Partners withdrew a net $15.8M in Q3 2017, closing 26 positions and reducing 31 holdings. Its most notable exit was Arista Networks, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Worth Venture Partners opened a new position in PTC Therapeutics worth $1.32M.

  • Worth Venture Partners's largest Q3 2017 buy was PTC Therapeutics: 66,196 shares worth $1.32M.
  • Worth Venture Partners added most to NetEase in Q3 2017, an estimated $589K increase.
  • Worth Venture Partners's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $690K.
  • Worth Venture Partners fully exited Arista Networks in Q3 2017, selling an estimated $1.9M.
  • Worth Venture Partners's ten largest holdings make up 55% of its $115M portfolio in Q3 2017.
  • Worth Venture Partners opened 40 new positions and closed 26 in Q3 2017.
  • Worth Venture Partners's portfolio value fell 0.58% quarter-over-quarter to $115M.

Based on Worth Venture Partners's 13F filing for Q3 2017, filed 7 Nov 2017.